These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 15864503)
81. Crystal Structure of Catechol O-Methyltransferase Complexed with Nitecapone. Iijima H; Takebe K; Suzuki M; Kobayashi H; Takamiya T; Saito H; Niwa N; Kuwada-Kusunose T Chem Pharm Bull (Tokyo); 2020; 68(5):447-451. PubMed ID: 32378542 [TBL] [Abstract][Full Text] [Related]
82. Bioluminescence procedures for the measurement of NAD(P) dependent enzyme catalytic activities in submicrogram quantities of rabbit and human nephron structures. Guder WG; Pürschel S; Vandewalle A; Wirthensohn G J Clin Chem Clin Biochem; 1984 Feb; 22(2):129-40. PubMed ID: 6716053 [TBL] [Abstract][Full Text] [Related]
83. Inhibition of human erythrocyte and gastroduodenal catechol-O-methyltransferase activity by nitecapone. Schultz E; Tarpila S; Bäckström AC; Gordin A; Nissinen E; Pohto P Eur J Clin Pharmacol; 1991; 40(6):577-80. PubMed ID: 1884738 [TBL] [Abstract][Full Text] [Related]
84. Norepinephrine metabolites in plasma as indicators of pharmacological inhibition of monoamine oxidase and catechol O-methyltransferase. Scheinin M; Illi A; Koulu M; Ojala-Karlsson P Adv Pharmacol; 1998; 42():367-70. PubMed ID: 9327918 [No Abstract] [Full Text] [Related]
85. Distribution of alpha 1B-adrenergic receptor mRNA expression along rat nephron segments. Umemura S; Yamaguchi S; Tamura K; Hibi K; Nyui N; Ishigami T; Kihara M; Yabana M; Ishii M Kidney Int; 1997 May; 51(5):1548-52. PubMed ID: 9150472 [TBL] [Abstract][Full Text] [Related]
86. Kinetic interactions of dopamine and dobutamine with human catechol-O-methyltransferase and monoamine oxidase in vitro. Yan M; Webster LT; Blumer JL J Pharmacol Exp Ther; 2002 Apr; 301(1):315-21. PubMed ID: 11907189 [TBL] [Abstract][Full Text] [Related]
87. Catechol-O-methyltransferase mRNA in the kidney and its appearance during ontogeny. Meister B; Bean AJ; Aperia A Kidney Int; 1993 Oct; 44(4):726-33. PubMed ID: 8258949 [TBL] [Abstract][Full Text] [Related]
88. Aromatic L-amino acid decarboxylase activity along the rat nephron. Hayashi M; Yamaji Y; Kitajima W; Saruta T Am J Physiol; 1990 Jan; 258(1 Pt 2):F28-33. PubMed ID: 2301593 [TBL] [Abstract][Full Text] [Related]
89. Dopamine in the Pathophysiology of Preeclampsia and Gestational Hypertension: Monoamine Oxidase (MAO) and Catechol-O-methyl Transferase (COMT) as Possible Mechanisms. Phoswa WN Oxid Med Cell Longev; 2019; 2019():3546294. PubMed ID: 31871546 [TBL] [Abstract][Full Text] [Related]
90. Contribution of leucine to oxidative metabolism of the rat medullary thick ascending limb. Trinh-Trang-Tan MM; Levillain O; Bankir L Pflugers Arch; 1988 Jun; 411(6):676-80. PubMed ID: 3137523 [TBL] [Abstract][Full Text] [Related]
91. Effects of salt depletion on the kidney: changes in medullary oxygenation and thick ascending limb size. Stillman IE; Brezis M; Heyman SN; Epstein FH; Spokes K; Rosen S J Am Soc Nephrol; 1994 Feb; 4(8):1538-45. PubMed ID: 8025227 [TBL] [Abstract][Full Text] [Related]
92. Distribution of enzymes of adenylate and guanylate nucleotide metabolism in rat nephron. Cole BR; Hays AE; Boylan JG; Burch HB; Lowry OH Am J Physiol; 1982 Oct; 243(4):F349-55. PubMed ID: 6289676 [TBL] [Abstract][Full Text] [Related]
93. Differential effect of dopamine catabolism and uptake inhibition on dopamine-induced calcium dysregulation and viability loss. Cantuti-Castelvetri I; Joseph JA Free Radic Biol Med; 1999 Dec; 27(11-12):1393-404. PubMed ID: 10641734 [TBL] [Abstract][Full Text] [Related]
94. Cyclic AMP-dependent protein kinase activity and endogenous protein phosphorylation in isolated cortical segments of rabbit nephron. Kimura K; Sudo J; Yazawa T; Koseki C; Endou H; Sakai F Jpn J Pharmacol; 1982 Feb; 32(1):131-7. PubMed ID: 6283214 [TBL] [Abstract][Full Text] [Related]
95. A kinetic investigation of the pulmonary metabolism of dopamine in rats shows marked differences compared with noradrenaline. Scarcella DL; Bryan-Lluka LJ Naunyn Schmiedebergs Arch Pharmacol; 1995 May; 351(5):491-9. PubMed ID: 7643912 [TBL] [Abstract][Full Text] [Related]
96. Effect of dexamethasone on monoamine oxidase inhibiton by iproniazid in rat brain. Veals JW; Korduba CA; Symchowicz S Eur J Pharmacol; 1977 Feb; 41(3):291-9. PubMed ID: 837973 [TBL] [Abstract][Full Text] [Related]
97. Evidence for an extraneuronal location of monoamine oxidase in renal tissues. Caramona MM; Soares-da-Silva P Naunyn Schmiedebergs Arch Pharmacol; 1990 May; 341(5):411-3. PubMed ID: 2366877 [TBL] [Abstract][Full Text] [Related]
98. Studies on the nature of the antagonistic actions of dopamine and 5-hydroxytryptamine in renal tissues. Soares-da-Silva P; Vieira-Coelho MA; Pinto-do-O PC; Pestana M; Bertorello AM Hypertens Res; 1995 Jun; 18 Suppl 1():S47-51. PubMed ID: 8529074 [TBL] [Abstract][Full Text] [Related]
99. The effects of soman in vitro on catechol-O-methyltransferase and monoamine oxidase activities in rabbit tissues. Hsu CH; Hu CY; Robinson CP J Biochem Toxicol; 1990; 5(3):183-5. PubMed ID: 2283669 [TBL] [Abstract][Full Text] [Related]
100. Renal metabolism of glucose: anatomical sites of hexokinase activity in the rat nephron. Schmidt U; Marosvari I; Dubach UC FEBS Lett; 1975 Apr; 53(1):26-8. PubMed ID: 1140392 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]